Global and United States Oncology (Anti-cancer Drugs) Market Report & Forecast 2024-2031

Report ID: 1841172 | Published Date: Jan 2025 | No. of Page: 104 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Oncology (Anti-cancer Drugs) Product Introduction
    1.2 Global Oncology (Anti-cancer Drugs) Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Oncology (Anti-cancer Drugs) Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Oncology (Anti-cancer Drugs) Sales in Volume for the Year 2017-2028
    1.3 United States Oncology (Anti-cancer Drugs) Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Oncology (Anti-cancer Drugs) Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Oncology (Anti-cancer Drugs) Sales in Volume for the Year 2017-2028
    1.4 Oncology (Anti-cancer Drugs) Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Oncology (Anti-cancer Drugs) in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Oncology (Anti-cancer Drugs) Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Oncology (Anti-cancer Drugs) Market Dynamics
        1.5.1 Oncology (Anti-cancer Drugs) Industry Trends
        1.5.2 Oncology (Anti-cancer Drugs) Market Drivers
        1.5.3 Oncology (Anti-cancer Drugs) Market Challenges
        1.5.4 Oncology (Anti-cancer Drugs) Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Oncology (Anti-cancer Drugs) Market Segment by Type
        2.1.1 Blood Cancer
        2.1.2 Breast Cancer
        2.1.3 Gastrointestinal Cancer
        2.1.4 Prostate Cancer
        2.1.5 Others
    2.2 Global Oncology (Anti-cancer Drugs) Market Size by Type
        2.2.1 Global Oncology (Anti-cancer Drugs) Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Oncology (Anti-cancer Drugs) Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Oncology (Anti-cancer Drugs) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Oncology (Anti-cancer Drugs) Market Size by Type
        2.3.1 United States Oncology (Anti-cancer Drugs) Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Oncology (Anti-cancer Drugs) Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Oncology (Anti-cancer Drugs) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Oncology (Anti-cancer Drugs) Market Segment by Application
        3.1.1 Chemotherapy
        3.1.2 Targeted Therapy
        3.1.3 Immunotherapy (Biologic Therapy)
        3.1.4 Hormonal Therapy
        3.1.5 Others
    3.2 Global Oncology (Anti-cancer Drugs) Market Size by Application
        3.2.1 Global Oncology (Anti-cancer Drugs) Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Oncology (Anti-cancer Drugs) Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Oncology (Anti-cancer Drugs) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Oncology (Anti-cancer Drugs) Market Size by Application
        3.3.1 United States Oncology (Anti-cancer Drugs) Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Oncology (Anti-cancer Drugs) Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Oncology (Anti-cancer Drugs) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Oncology (Anti-cancer Drugs) Competitor Landscape by Company
    4.1 Global Oncology (Anti-cancer Drugs) Market Size by Company
        4.1.1 Top Global Oncology (Anti-cancer Drugs) Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Oncology (Anti-cancer Drugs) Revenue by Manufacturer (2017-2022)
        4.1.3 Global Oncology (Anti-cancer Drugs) Sales by Manufacturer (2017-2022)
        4.1.4 Global Oncology (Anti-cancer Drugs) Price by Manufacturer (2017-2022)
    4.2 Global Oncology (Anti-cancer Drugs) Concentration Ratio (CR)
        4.2.1 Oncology (Anti-cancer Drugs) Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Oncology (Anti-cancer Drugs) in 2021
        4.2.3 Global Oncology (Anti-cancer Drugs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Oncology (Anti-cancer Drugs) Manufacturing Base Distribution, Product Type
        4.3.1 Global Oncology (Anti-cancer Drugs) Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Oncology (Anti-cancer Drugs) Product Type
        4.3.3 Date of International Manufacturers Enter into Oncology (Anti-cancer Drugs) Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Oncology (Anti-cancer Drugs) Market Size by Company
        4.5.1 Top Oncology (Anti-cancer Drugs) Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Oncology (Anti-cancer Drugs) Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Oncology (Anti-cancer Drugs) Sales by Players (2020, 2021 & 2022)
5 Global Oncology (Anti-cancer Drugs) Market Size by Region
    5.1 Global Oncology (Anti-cancer Drugs) Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Oncology (Anti-cancer Drugs) Market Size in Volume by Region (2017-2028)
        5.2.1 Global Oncology (Anti-cancer Drugs) Sales in Volume by Region: 2017-2022
        5.2.2 Global Oncology (Anti-cancer Drugs) Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Oncology (Anti-cancer Drugs) Market Size in Value by Region (2017-2028)
        5.3.1 Global Oncology (Anti-cancer Drugs) Sales in Value by Region: 2017-2022
        5.3.2 Global Oncology (Anti-cancer Drugs) Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Oncology (Anti-cancer Drugs) Market Size YoY Growth 2017-2028
        6.1.2 North America Oncology (Anti-cancer Drugs) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Oncology (Anti-cancer Drugs) Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Oncology (Anti-cancer Drugs) Market Size YoY Growth 2017-2028
        6.3.2 Europe Oncology (Anti-cancer Drugs) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Oncology (Anti-cancer Drugs) Market Size YoY Growth 2017-2028
        6.4.2 Latin America Oncology (Anti-cancer Drugs) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Oncology (Anti-cancer Drugs) Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Oncology (Anti-cancer Drugs) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Roche
        7.1.1 Roche Corporation Information
        7.1.2 Roche Description and Business Overview
        7.1.3 Roche Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Roche Oncology (Anti-cancer Drugs) Products Offered
        7.1.5 Roche Recent Development
    7.2 Novartis
        7.2.1 Novartis Corporation Information
        7.2.2 Novartis Description and Business Overview
        7.2.3 Novartis Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Novartis Oncology (Anti-cancer Drugs) Products Offered
        7.2.5 Novartis Recent Development
    7.3 Celgene
        7.3.1 Celgene Corporation Information
        7.3.2 Celgene Description and Business Overview
        7.3.3 Celgene Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Celgene Oncology (Anti-cancer Drugs) Products Offered
        7.3.5 Celgene Recent Development
    7.4 Amgen
        7.4.1 Amgen Corporation Information
        7.4.2 Amgen Description and Business Overview
        7.4.3 Amgen Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Amgen Oncology (Anti-cancer Drugs) Products Offered
        7.4.5 Amgen Recent Development
    7.5 Johnson & Johnson
        7.5.1 Johnson & Johnson Corporation Information
        7.5.2 Johnson & Johnson Description and Business Overview
        7.5.3 Johnson & Johnson Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Johnson & Johnson Oncology (Anti-cancer Drugs) Products Offered
        7.5.5 Johnson & Johnson Recent Development
    7.6 GlaxoSmithKline
        7.6.1 GlaxoSmithKline Corporation Information
        7.6.2 GlaxoSmithKline Description and Business Overview
        7.6.3 GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 GlaxoSmithKline Oncology (Anti-cancer Drugs) Products Offered
        7.6.5 GlaxoSmithKline Recent Development
    7.7 Eli lilly & Co
        7.7.1 Eli lilly & Co Corporation Information
        7.7.2 Eli lilly & Co Description and Business Overview
        7.7.3 Eli lilly & Co Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Eli lilly & Co Oncology (Anti-cancer Drugs) Products Offered
        7.7.5 Eli lilly & Co Recent Development
    7.8 Pfizer
        7.8.1 Pfizer Corporation Information
        7.8.2 Pfizer Description and Business Overview
        7.8.3 Pfizer Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Pfizer Oncology (Anti-cancer Drugs) Products Offered
        7.8.5 Pfizer Recent Development
    7.9 Merck & Co.
        7.9.1 Merck & Co. Corporation Information
        7.9.2 Merck & Co. Description and Business Overview
        7.9.3 Merck & Co. Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 Merck & Co. Oncology (Anti-cancer Drugs) Products Offered
        7.9.5 Merck & Co. Recent Development
    7.10 Sanofi
        7.10.1 Sanofi Corporation Information
        7.10.2 Sanofi Description and Business Overview
        7.10.3 Sanofi Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Sanofi Oncology (Anti-cancer Drugs) Products Offered
        7.10.5 Sanofi Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Oncology (Anti-cancer Drugs) Industry Chain Analysis
    8.2 Oncology (Anti-cancer Drugs) Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Oncology (Anti-cancer Drugs) Distributors
    8.3 Oncology (Anti-cancer Drugs) Production Mode & Process
    8.4 Oncology (Anti-cancer Drugs) Sales and Marketing
        8.4.1 Oncology (Anti-cancer Drugs) Sales Channels
        8.4.2 Oncology (Anti-cancer Drugs) Distributors
    8.5 Oncology (Anti-cancer Drugs) Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Oncology (Anti-cancer Drugs) CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Oncology (Anti-cancer Drugs) Market Trends
    Table 3. Oncology (Anti-cancer Drugs) Market Drivers
    Table 4. Oncology (Anti-cancer Drugs) Market Challenges
    Table 5. Oncology (Anti-cancer Drugs) Market Restraints
    Table 6. Global Oncology (Anti-cancer Drugs) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Oncology (Anti-cancer Drugs) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Oncology (Anti-cancer Drugs) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Oncology (Anti-cancer Drugs) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Oncology (Anti-cancer Drugs) Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Oncology (Anti-cancer Drugs) Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Oncology (Anti-cancer Drugs) Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Oncology (Anti-cancer Drugs) Sales by Manufacturer, (K MT), 2017-2022
    Table 14. Global Oncology (Anti-cancer Drugs) Sales Share by Manufacturer, 2017-2022
    Table 15. Global Oncology (Anti-cancer Drugs) Price by Manufacturer (2017-2022) & (USD/MT)
    Table 16. Global Oncology (Anti-cancer Drugs) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Oncology (Anti-cancer Drugs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology (Anti-cancer Drugs) as of 2021)
    Table 18. Top Players of Oncology (Anti-cancer Drugs) in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Oncology (Anti-cancer Drugs) Product Type
    Table 20. Date of International Manufacturers Enter into Oncology (Anti-cancer Drugs) Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Oncology (Anti-cancer Drugs) Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Oncology (Anti-cancer Drugs) Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Oncology (Anti-cancer Drugs) Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Oncology (Anti-cancer Drugs) Sales by Players, (K MT), 2020, 2021 & 2022
    Table 26. United States Oncology (Anti-cancer Drugs) Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Oncology (Anti-cancer Drugs) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Oncology (Anti-cancer Drugs) Sales in Volume by Region (2017-2022) & (K MT)
    Table 29. Global Oncology (Anti-cancer Drugs) Sales in Volume Forecast by Region (2023-2028) & (K MT)
    Table 30. Global Oncology (Anti-cancer Drugs) Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Oncology (Anti-cancer Drugs) Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Oncology (Anti-cancer Drugs) Sales in Volume by Country (2017-2028) & (K MT)
    Table 33. North America Oncology (Anti-cancer Drugs) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Oncology (Anti-cancer Drugs) Sales in Volume by Region (2017-2028) & (K MT)
    Table 35. Asia Pacific Oncology (Anti-cancer Drugs) Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Oncology (Anti-cancer Drugs) Sales in Volume by Country (2017-2028) & (K MT)
    Table 37. Europe Oncology (Anti-cancer Drugs) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Oncology (Anti-cancer Drugs) Sales in Volume by Country (2017-2028) & (K MT)
    Table 39. Latin Americaa Oncology (Anti-cancer Drugs) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Oncology (Anti-cancer Drugs) Sales in Volume by Country (2017-2028) & (K MT)
    Table 41. Middle East and Africa Oncology (Anti-cancer Drugs) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Roche Corporation Information
    Table 43. Roche Description and Business Overview
    Table 44. Roche Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 45. Roche Oncology (Anti-cancer Drugs) Product
    Table 46. Roche Recent Development
    Table 47. Novartis Corporation Information
    Table 48. Novartis Description and Business Overview
    Table 49. Novartis Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 50. Novartis Product
    Table 51. Novartis Recent Development
    Table 52. Celgene Corporation Information
    Table 53. Celgene Description and Business Overview
    Table 54. Celgene Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 55. Celgene Product
    Table 56. Celgene Recent Development
    Table 57. Amgen Corporation Information
    Table 58. Amgen Description and Business Overview
    Table 59. Amgen Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 60. Amgen Product
    Table 61. Amgen Recent Development
    Table 62. Johnson & Johnson Corporation Information
    Table 63. Johnson & Johnson Description and Business Overview
    Table 64. Johnson & Johnson Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. Johnson & Johnson Product
    Table 66. Johnson & Johnson Recent Development
    Table 67. GlaxoSmithKline Corporation Information
    Table 68. GlaxoSmithKline Description and Business Overview
    Table 69. GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 70. GlaxoSmithKline Product
    Table 71. GlaxoSmithKline Recent Development
    Table 72. Eli lilly & Co Corporation Information
    Table 73. Eli lilly & Co Description and Business Overview
    Table 74. Eli lilly & Co Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 75. Eli lilly & Co Product
    Table 76. Eli lilly & Co Recent Development
    Table 77. Pfizer Corporation Information
    Table 78. Pfizer Description and Business Overview
    Table 79. Pfizer Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 80. Pfizer Product
    Table 81. Pfizer Recent Development
    Table 82. Merck & Co. Corporation Information
    Table 83. Merck & Co. Description and Business Overview
    Table 84. Merck & Co. Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 85. Merck & Co. Product
    Table 86. Merck & Co. Recent Development
    Table 87. Sanofi Corporation Information
    Table 88. Sanofi Description and Business Overview
    Table 89. Sanofi Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 90. Sanofi Product
    Table 91. Sanofi Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Oncology (Anti-cancer Drugs) Customers List
    Table 95. Oncology (Anti-cancer Drugs) Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oncology (Anti-cancer Drugs) Product Picture
    Figure 2. Global Oncology (Anti-cancer Drugs) Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Oncology (Anti-cancer Drugs) Market Size 2017-2028 (US$ Million)
    Figure 4. Global Oncology (Anti-cancer Drugs) Sales 2017-2028 (K MT)
    Figure 5. United States Oncology (Anti-cancer Drugs) Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Oncology (Anti-cancer Drugs) Market Size 2017-2028 (US$ Million)
    Figure 7. United States Oncology (Anti-cancer Drugs) Sales 2017-2028 (K MT)
    Figure 8. United States Oncology (Anti-cancer Drugs) Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Oncology (Anti-cancer Drugs) Market Share in Global, in Volume (K MT) 2017-2028
    Figure 10. Oncology (Anti-cancer Drugs) Report Years Considered
    Figure 11. Product Picture of Blood Cancer
    Figure 12. Product Picture of Breast Cancer
    Figure 13. Product Picture of Gastrointestinal Cancer
    Figure 14. Product Picture of Prostate Cancer
    Figure 15. Product Picture of Others
    Figure 16. Global Oncology (Anti-cancer Drugs) Market Share by Type in 2022 & 2028
    Figure 17. Global Oncology (Anti-cancer Drugs) Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global Oncology (Anti-cancer Drugs) Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global Oncology (Anti-cancer Drugs) Sales by Type (2017-2028) & (K MT)
    Figure 20. Global Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global Oncology (Anti-cancer Drugs) Price by Type (2017-2028) & (USD/MT)
    Figure 22. United States Oncology (Anti-cancer Drugs) Market Share by Type in 2022 & 2028
    Figure 23. United States Oncology (Anti-cancer Drugs) Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States Oncology (Anti-cancer Drugs) Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States Oncology (Anti-cancer Drugs) Sales by Type (2017-2028) & (K MT)
    Figure 26. United States Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States Oncology (Anti-cancer Drugs) Price by Type (2017-2028) & (USD/MT)
    Figure 28. Product Picture of Chemotherapy
    Figure 29. Product Picture of Targeted Therapy
    Figure 30. Product Picture of Immunotherapy (Biologic Therapy)
    Figure 31. Product Picture of Hormonal Therapy
    Figure 32. Product Picture of Others
    Figure 33. Global Oncology (Anti-cancer Drugs) Market Share by Application in 2022 & 2028
    Figure 34. Global Oncology (Anti-cancer Drugs) Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. Global Oncology (Anti-cancer Drugs) Sales Market Share in Value by Application (2017-2028)
    Figure 36. Global Oncology (Anti-cancer Drugs) Sales by Application (2017-2028) & (K MT)
    Figure 37. Global Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Application (2017-2028)
    Figure 38. Global Oncology (Anti-cancer Drugs) Price by Application (2017-2028) & (USD/MT)
    Figure 39. United States Oncology (Anti-cancer Drugs) Market Share by Application in 2022 & 2028
    Figure 40. United States Oncology (Anti-cancer Drugs) Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 41. United States Oncology (Anti-cancer Drugs) Sales Market Share in Value by Application (2017-2028)
    Figure 42. United States Oncology (Anti-cancer Drugs) Sales by Application (2017-2028) & (K MT)
    Figure 43. United States Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Application (2017-2028)
    Figure 44. United States Oncology (Anti-cancer Drugs) Price by Application (2017-2028) & (USD/MT)
    Figure 45. North America Oncology (Anti-cancer Drugs) Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 46. North America Oncology (Anti-cancer Drugs) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. U.S. Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Canada Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Europe Oncology (Anti-cancer Drugs) Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 50. Europe Oncology (Anti-cancer Drugs) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 51. Germany Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. France Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.K. Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Italy Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Russia Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Asia-Pacific Oncology (Anti-cancer Drugs) Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 57. Asia-Pacific Oncology (Anti-cancer Drugs) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 58. China Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Japan Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. South Korea Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. India Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Australia Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Taiwan Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Indonesia Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Thailand Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Malaysia Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Philippines Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Latin America Oncology (Anti-cancer Drugs) Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 69. Latin America Oncology (Anti-cancer Drugs) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Mexico Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Brazil Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Argentina Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Middle East & Africa Oncology (Anti-cancer Drugs) Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 74. Middle East & Africa Oncology (Anti-cancer Drugs) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 75. Turkey Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Saudi Arabia Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. U.A.E Oncology (Anti-cancer Drugs) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 78. Oncology (Anti-cancer Drugs) Value Chain
    Figure 79. Oncology (Anti-cancer Drugs) Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Novartis
Celgene
Amgen
Johnson & Johnson
GlaxoSmithKline
Eli lilly & Co
Pfizer
Merck & Co.
Sanofi
Frequently Asked Questions
Oncology (Anti-cancer Drugs) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oncology (Anti-cancer Drugs) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oncology (Anti-cancer Drugs) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports